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Tumor bulk has been recognized as an important pro-
gnostic factor in the treatment of malignancy. The purpose of
the present study is to investigate the prognostic value of
tumor volume in nasopharyngeal carcinoma. Sixty patients
with nasopharyngeal carcinoma were included in this study.
Tumor contour was outlined on each of the computed tomo-
graphy (CT) images using an image analyzer. The primary
tumor volume (PTV) and nodal tumor volume (NTV) were
calculated by a summation-of-areas technique, and the maxi-
mal perimeter of primary tumor (MPP) was measured. The
loco-regional control rates and disease-specific survival rates
were analyzed according to several variables. The patients
had a 5-year local control rate of 75.5%, 5-year nodal control
rate of 74.6%, and 5-year disease-specific survival rate of
60.2%. Large PTV (> 30 cm
3) was associated with a signi-
ficantly lower local control (p=0.005). Large NTV (> 5 cm
3)
was associated with a significantly lower nodal control
(p=0.019) and lower disease- specific survival (p=0.046).
Large MPP (> 18 cm) was associated with a significantly
lower local control (p=0.017). In multivariate analysis, the
PTV and NTV were found to be independent factors in
predicting the local (p=0.015) and nodal (p=0.039) control,
respectively. The NTV (p=0.012) and cranial nerve involve-
ment (p=0.009) were factors that predicted disease-specific
survival. Our results suggest that the estimation of tumor
volume may identify a subgroup of patients with a greater
risk of loco-regional failure and can be used to refine the
current staging system.
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INTRODUCTION
Due to anatomical location, nasopharyngeal
cancers are considered unresectable, and radiation
has been the conventional treatment approach.
1,2
Because of high rates of both local and distant
failures from radiation alone, recently more ad-
vanced radiotherapy and combined chemoradio-
therapy have been actively used.
3,4
The tumor stage, histopathologic type, involve-
ment of lymph nodes in the lower neck, and
intracranial extension have been well established
as prognostic factors of nasopharyngeal carci-
noma.
5-7 In addition to these factors, tumor bulk
has been recognized as an important prognostic
factor in the treatment of malignancy. Fletcher
8
first suggested that tumor volume indicated the
number of tumor clonogen that should be re-
moved. An increasing tumor bulk relates to an
increasing number of tumor clonogen requiring
sterilization.
9-12 In nonoperative therapy of certain
malignancies like lung cancer, the largest dimen-
sional and bi-dimensional product, which can be
easily assessed clinically, were reported as a
reliable tool in evaluating response. This tech-
nique is similar to the more difficult method of
measuring tumor volume.
The main purpose of any staging system is to
segregate patients into subgroups with different
prognosis, in order for the appropriate treatment
strategy to be employed. The Ho's and AJCC
staging systems
13,14 have been widely used for
nasopharyngeal carcinoma. Both staging systems
classify the T stage according to the anatomic site
involved and intracranial extension, not to the
three-dimensional tumor volume or tumor diame-
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ter. Due to the limitation of the current staging
system for prognosis, a refined staging system is
needed. This study is aimed at delineating the
relationship between tumor volumetric measure-
ment and treatment results in nasopharyngeal
carcinoma, and finding more accurate prognostic
factors in staging nasopharyngeal carcinoma.
MATERIALS AND METHODS
Patient population
Sixty patients with newly diagnosed nasophar-
yngeal carcinoma treated with chemoradiotherapy
in Chonnam National University Hospital from
January 1991 to September 2001 were analyzed
retrospectively. All the patients were staged
according to 1997 AJCC
14 and had pretreatment
computed tomography (CT) scans for their tumor
volume measurement. There were 48 male (80.0
%) and 12 female (20.0%) patients, with a median
age of 53 (range, 19-68 years). All the patients
received chemotherapy and radiation therapy. The
patients received one to three cycles of chemo-
therapy consisting of cisplatin and 5-fluorouracil
(5-FU). Thirty-eight patients before 1998 received
neoadjuvant chemotherapy (cisplatin 100 mg/m
2
and 5-FU 1000 mg/m
2) and 22 patients after 1998
received neoadjuvant and concurrent chemoradio-
therapy (cisplatin 60-80 mg/m
2 and 5-FU 600-800
mg/m
2). All patients received conventional radia-
tion therapy with a fraction size of 180 or 200 cGy
once a day, and 5 times a week by a 6MV photon
linear accelerator. The total delivered dose was
64.8-77.0 Gy (median: 70.0 Gy) for the primary
tumor and 45.0 Gy was prescribed for the elective
neck irradiation. The follow-up period ranged
from 11 to 144 months with a median of 51
months (Table 1).
Volume determination
A pretreatment contrast CT scan was performed
Table 1. Patients Characteristics
Characteristics No. of patients (n=60)
Age
Range 19-68 years
Median 53 years
Gender
Male/Female 48 (80%)/12 (20%)
Histopathology
WHO type I/II/III 3 (5%)/34 (57%)/23 (38%)
T
T1/T2/T3/T4 14 (23%)/21 (35%)/10 (17%)/15 (25%)
N
N0/N1/N2/N3 14 (23%)/21 (35%)/21 (35%)/4 (7%)
Stage
I/II/III/IV 2 (3%)/18 (30%)/21 (35%)/19 (32%)
Chemoradiotherapy
Neoadjuvant/Concurrent 38 (63%)/22 (37%)
Total radiation dose (Gy, median) 64.8-77.0 Gy (70.0)
Radiation duration (days, median) 50-84 days (53)Tumor Volume in Nasopharyngeal Carcinoma
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in all patients with contiguous axial scans of 3-5
mm slice thickness. Patients were staged ac-
cording to the AJCC stage classification system for
nasopharyngeal carcinoma. The primary tumor
and nodes were outlined separately. Neck node
involvement was diagnosed based on the criteria
recommended by Mancuso et al.
15 and Som
16: 1)
a discrete mass more than 1 cm in diameter, not
enhancing to the extent expected of vessels in the
lymph node bearing region of the neck or 2)
presence of central necrosis of suspected nodal
mass or 3) grouping of three or more contiguous
nodes, each 8-15 mm in diameter. Nodes that were
embedded within the primary tumor (e.g., retro-
pharyngeal nodes) were included as part of the
tumor.
All CT scans were digitalized using a film
scanner. The contour of the primary tumor and
lymph nodes was outlined using the computer
image analysis software Image-Proplus 4.0 (Media
Cybernetics, USA) and the area calculated. The
maximal perimeter was calculated in the primary
tumor. In the lymph nodes, the maximal perime-
ter could not be calculated due to a large error in
measuring multiple lymph nodes of varying
contiguity. The primary tumor volume (PTV) and
nodal tumor volume (NTV) were then calculated
by a summation-of-areas technique. The total
tumor volume (TTV) was outlined by adding the
PTV and NTV. The PTV, NTV, TTV, and MPP
were divided into two groups with the cut-off
values decided by a stepwise pattern.
Statistical analysis
The correlations between T stage and PTV, N
stage and NTV, staging and TTV were analyzed.
For the survival analysis, each parameter was
divided into two groups as follows: T stage
(T1/T2 vs. T3/T4), N stage (N0/N1 vs. N2/N3),
MPP ( 18 cm vs. > 18 cm), PTV ( 30 cm
3 vs.
> 30 cm
3), NTV ( 5 cm
3 vs. >5 cm
3), TTV ( 35
cm
3 vs. > 35 cm
3), chemoradiotherapy (neoadju-
vant vs. concurrent), histopathologic type (WHO
type I vs. II vs. III), intracranial extension, cranial
nerve involvement, and skull base erosion.
The product-limit method of Kaplan and Meier
and log-rank test were used for the univariate
analysis of prognostic significance of the parame-
ters on treatment results (local control rate, nodal
control rate and disease-specific survival). Mul-
tivariate analysis was also performed using the
Cox proportional hazard model. A p-value less
than 0.05 was considered to be statistically signifi-
cant.
RESULTS
Volumetric analysis of primary tumor and
metastatic lymphadenopathies
The PTV, NTV, and TTV were 0.4 to 77.5 cm
3
(median, 12.2 cm
3), 2.7-121.0 cm
3 (median, 6.6cm
3),
and 0.4 to 184.8 cm
3 (median, 27.8 cm
3), respec-
tively, and the MPP was 2.5 to 27.1 cm with a
median of 15.6 cm.
Relation between tumor volume and stage
The PTV ( 30 cm
3, n=46 vs. > 30 cm
3, n=14),
NTV ( 5 cm
3, n=27 vs. > 5 cm
3, n=33), and TTV
( 35 cm
3, n=37 vs. > 35 cm
3, n=23) were corre-
lated with T stage (p=0.001), N stage (p < 0.001),
and stage group (p=0.028), respectively, although
there were variations such as small volume and
high stage, or vice versa.
Treatment outcome
Survival analysis showed the 5-year local con-
trol rate to be 75.5%, the 5-year nodal control rate
to be 74.6%, and the 5-year disease-specific sur-
vival rate to be 60.2%.
Univariate analysis of tumor volume and treatment
outcome
Large PTV (> 30 cm
3) was associated with a
significantly lower local control (p=0.004). Large
NTV (> 5 cm
3) was associated with a lower nodal
control (p=0.019) and lower disease-specific sur-
vival rate (p=0.046) with statistical significance.
Although a lower disease-specific survival rate
was also observed in patients with a large PTV or
TTV, there was no statistical significance. The
MPP was associated with a local control rate with
statistical significance (p=0.017) (Table 2).Jeong-Hyun Kim and Joon-Kyoo Lee
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Multivariate analysis of prognostic factors in naso-
pharyngeal carcinoma
The results are summarized in Table 3. Only
PTV was found to be an independent predictor of
local control, with T stage or MPP no longer a
significant factor. In nodal control, only NTV was
found to be an independent prognostic factor, N
stage no longer being a significant factor. In
disease-specific survival, the NTV and cranial
nerve involvement were found to be independent
prognostic factors.
DISCUSSION
Tumor bulk has been well recognized as one of
the major prognostic factors in the treatment of
malignancy, as increasing tumor bulk relates to an
Table 3. Multivariate Analysis of Prognostic Factors in Nasopharyngeal Carcinoma
End points Variables Relative risk (95% C.I.) p-value
Local control PTV 3.57 (1.10-12.13) 0.015
T stage >0.05
MPP >0.05
Chemoradiotherapy >0.05
Histopathology >0.05
Nodal control NTV 2.72 (1.02-9.03) 0.039
N stage >0.05
Disease specific survival PTV >0.05
NTV 3.61 (1.32-9.80) 0.012
TTV >0.05
T stage >0.05
N stage >0.05
Cranial nerve involvement 3.78 (1.38-10.39) 0.009
PTV, primary tumor volume; MPP, maximal perimeter of primary tumor; NTV, nodal tumor volume; TTV, total tumor volume.
Table 2. Univariate Analysis of Treatment Outcome by Tumor Volume and Perimeter
Factors
5-year local
control rate
5-year nodal
control rate
5-year disease specific
survival rate
PTV 30 cm
3 84.2%
p=0.004
64.5%
p=0.27
> 30 cm
3 46.9% 44.2%
NTV 5 cm
3 100%
p=0.019
73.6%
p=0.046
> 5 cm
3 64% 49.0%
TTV 35 cm
3 70.0%
p=0.09
> 35 cm
3 43.0%
MPP 18 cm 84.7%
p=0.017
66.7%
p=0.178
> 18 cm 57.4% 47.4%
PTV, primary tumor volume; NTV, nodal tumor volume; TTV, total tumor volume; MPP, maximal perimeter of primary tumor.Tumor Volume in Nasopharyngeal Carcinoma
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increasing number of tumor clonogen needing to
be sterilized.
5-9 The prognostic significance of
tumor bulk has been recognized and adopted in
the staging systems of most malignancies, which
often employs a crude measurement of tumor
diameter and assessment of tumor extent. Such
methods of evaluating tumor bulk may be less
applicable in tumors that tend to be infiltrative
and irregularly shaped, especially if the tumor is
difficult to assess and measure clinically.
Nasopharyngeal carcinoma represents a tumor
with a highly infiltrative growth pattern, with a
propensity to spread along parapharyngeal space
as well as to the skull base and foramina.
17 In
addition, there is a variation of the anatomic
structure of the nasopharynx between individuals.
The tumor volume cannot be easily assessed
clinically, and even with the help of imaging, the
irregularly shaped tumor would make a crude
measurement difficult and have limited accuracy.
Accurate measurement of tumor volume in
nasopharyngeal carcinoma therefore requires a
detailed outlining of the tumor extent from
imaging, and a calculation of tumor volume from
a three-dimensional perspective.
Recently, tumor volume has been actively
studied in head and neck malignancies. The
ability of tumor volume to predict local control in
supraglottic and glottic carcinoma,
18,19 and in
oropharyngeal and hypopharyngeal carcinoma
20,21 was reported. Furthermore, Chua et al.
22
suggested that measurement of the primary tumor
volume in nasopharyngeal carcinoma offered a
more important prognostic value in predicting
local control than either Ho's or AJCC staging
systems. Both the Ho's and AJCC staging systems
for nasopharyngeal carcinoma classify the T stage
according to the anatomic sites and not to the
tumor bulk. The AJCC staging system classifies
the N stage according to bilaterality, the greatest
dimension, and extension to supraclavicular fossa.
The main purpose of any staging system is to
segregate patients into subgroups with different
prognosis so that an appropriate treatment
strategy can be employed. Due to the limitation of
the current staging systems to predict prognosis,
there has been an effort to refine the staging
system.
Although large tumor volume was more com-
monly observed in the higher stages (T stage, N
stage, stage group) of disease in this study, there
was substantial variation of tumor volume in all
stages. This finding means that similar values of
tumor volume could be classified in different
stages according to the direction of tumor exten-
sion.
Chua et al. reported that patients with large
PTV > 60 cm
3 had a poor chance of control of
nasopharyngeal carcinoma
22 and that 15 cm
3 was
the cutoff point that predicted the prognosis for
early T1 and T2 nasopharyngeal carcinoma.
23
Willner et al.
24 reported that patients with PTV >
64 cm
3 had a lower local control treated by radio-
therapy. Sze et al.
25 suggested that patients with
primary tumor-retropharyngeal lymph node
volumes over 15 cm
3 had lower local control and
that the local control rate increased by 1% as the
primary tumor volume increased by 1 cm
3. Our
study showed that patients with PTV over 30 cm
3
had lower local control and PTV was found to be
a significant factor in predicting local failure. The
T stage of the AJCC staging system failed to
predict local control in multivariate analysis.
Johnson et al.
26 reported that patients with TTV
over 35 cm
3 had lower local control. In our study,
TTV was divided into PTV and NTV. According
to analysis, PTV was significantly related to local
control rate and NTV was significantly related to
nodal control rate. Furthermore, NTV was signifi-
cantly related to disease-specific survival rate, as
patients with large NTV over 5 cm
3 had a statis-
tically lower survival rate. This differs from the
report of Chua et al.
23 that a large NTV over 4 cm
3
was related to a high distant failure rate without
any relationship to disease-specific survival. This
can be explained by the finding that the relatively
small tumor volume of lymph nodes in early
nasopharyngeal carcinoma was included in their
study. Although there was a report that disease-
specific survival varied according to the N stage,
23
it was not an independent prognostic factor of
survival in this multivariate analysis.
Tumor perimeter has not yet been studied for
treatment outcome. However, it was included in
this study due to its indication of irregularity of
tumor extension and its usage as the two-dimen-
sional data of tumor size. Although the MPP was
a significant parameter that predicted local controlJeong-Hyun Kim and Joon-Kyoo Lee
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in the univariate analysis, it was not significant in
the multivariate analysis where the tumor volume
was included. This suggests that nasopharyngeal
carcinoma tends to have an infiltrative growth
pattern, often with a highly irregular tumor
contour. The tumor perimeter is not as significant
as tumor volume due to its limitation as a two-
dimensional factor, even though it reflects the
irregularity of each tumor relatively well.
Cranial nerve involvement was recognized as a
prognostic factor of local control and survival,
irrespective of skull base erosion.
27 Intracranial
extension was reported to have an inverse correla-
tion with survival.
4 In our study, cranial nerve
involvement was found to be related to a lower
disease-specific survival rate. This may be ex-
plained by the extension of the tumor along
cranial nerves to other sites out of the port of
radiation.
Other factors contributing to apparent tumor
radioresistance must be considered. Although this
study demonstrated an inverse correlation
between tumor control and disease volume, there
were several failures in small tumors and cures in
cases with massive disease. This suggests that
other factors besides those studied here contribute
to radiation response. Cellular factors such as
repopulation, intrinsic radioresistance, and/or
reoxygenation and redistribution are suggested as
important variables for tumor control.
In conclusion, we suggest that in order to better
refine the staging system, volumetric analysis of
the primary tumor and lymph nodes, anatomic
sites involved, and intracranial extension should
be included in the current TNM staging system
for nasopharyngeal carcinoma.
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